Transplantation-Related Complications Predicted by Cytokine Gene Expression in the Mixed Lymphocyte Culture in Allogeneic Bone Marrow Transplants
- 1 January 1995
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 19 (1-2) , 27-32
- https://doi.org/10.3109/10428199509059660
Abstract
In this study, we have investigated cytokine (IL-1β, IL-2, IL-5, IL-6, IFN-γ, TNF-α) and T cell surface molecule (IL-2 receptor. CD28, CTLA-4) gene expression in two way mixed lymphocyte cultures (MLC) enhanced by concanavalin A (ConA) to assess whether this is a useful predictive method for severe graft-versus-host disease (GVHD) and graft failure in allogeneic bone marrow transplantation (allo BMT) patients. Our present study revealed increased mRNA expression of IL-2, IL-5 and IFN-y using this assay in patients with delayed engraftment followed by graft failure and patients who developed grade III acute GVHD. Elevated IL-2 and IFN-γ levels in MLC medium were also observed in these patients. Concerning T cell surface molecule gene expression in our modified MLC. IL-2 receptor gene expression was not altered so much in allo BMT patients, however, CD28 and CTLA-4 gene expression were elevated in patients with graft failure and severe acute GVHD. The elevated expression of cytokines (IL-2. IL-5 and IFN-y) and T cell surface molecules (CD28 and CTLA-4) mRNA in our modified MLC, in patients who developed severe lethal transplantation-related complications may suggest an important role for these molecules in inducing a strong alloresponse. Therefore, the detection of increased gene expression of those molecules, in our modified MLC system, appeared to be useful for predicting transplantation-related complications in allo BMT patients. In addition. this modified MLC assay may also be useful for the selection of the most compatible related and unrelated donors.Keywords
This publication has 30 references indexed in Scilit:
- Cytokine gene expression in the mixed lymphocyte culture in allogeneic bone marrow transplants as a predictive method for transplantation-related complicationsBritish Journal of Haematology, 1994
- PREDICTION BY A MODIFIED MIXED LEUKOCYTE REACTION ASSAY OF GRAFT-VERSUS-HOST DISEASE AND GRAFT REJECTION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1994
- RAPID ANALYSIS OF TUMOR NECROSIS FACTOR-ALPHA mRNA EXPRESSION DURING VENOOCCLUSIVE DISEASE OF THE LIVER AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION1Transplantation, 1993
- Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.The Journal of Experimental Medicine, 1993
- Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation MoleculeScience, 1992
- Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lgScience, 1992
- THE PREDICTIVE VALUE OF HLA-DR OLIGOTYPING FOR MLC RESPONSESTransplantation, 1992
- CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.The Journal of Experimental Medicine, 1992
- MODULATION OF EXPRESSION OF MHC ANTIGENS IN THE KIDNEYS OF MICE BY MURINE INTERFERONTransplantation, 1990
- INTERLEUKINS AND THE IMMUNE SYSTEM 2The Lancet, 1989